絞り込み

16735

広告

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.

著者 Gómez-Outes A , Terleira-Fernández AI , Suárez-Gea ML , Vargas-Castrillón E
BMJ.2012 ; 344():e3675.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Division of Pharmacology and Clinical Evaluation, Medicines for Human Use, Spanish Agency for Medicines and Medical Devices, Parque Empresarial Las Mercedes, Edificio 8, C/Campezo 1, Madrid, 28022, Spain.

スターを付ける スターを付ける     (158view , 0users)

Full Text Sources

Medical

Other Literature Sources

To analyse clinical outcomes with new oral anticoagulants for prophylaxis against venous thromboembolism after total hip or knee replacement.
PMID: 22700784 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード